NEW · Pharmaceuticals
MRK
Merck & Co Inc · $356.01B
144.30
+0.34%
Price
251 sessions shownTechnicals
from daily closesRSI · 14 day
48.6
Avg true range · 14d
2.25%
Volatility · 20d annualised
18.8%
Trend · 20d vs 50d
Up
vs 20-day average
-1.81%
vs 50-day average
1.41%
vs 200-day average
17.45%
200-day average
122.86
Internals
where it sits, and how hard it is being traded52-week low
82.01
52-week high
156.92
Volume vs its 20-day avg
1.00×
Beta vs the market
0.12
Sitting 83% of the way up its 52-week range (82.01 → 156.92)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Aug 25
156.92
Turned down · Sep 3
152.80
Turned down · Sep 22
153.57
Turned up · Aug 4
126.22
Turned up · Aug 28
145.75
Turned up · Sep 15
142.32
Fundamentals
P/E
112.20
Fwd P/E
—
P/S
5.35
P/B
4.97
EV/EBITDA
42.06
ROE
6.6%
ROA
2.4%
Gross margin
77.3%
Net margin
—
Debt / equity
0.94
Rev growth
4.6%
EPS growth
8.4%
Earnings
Next report
Oct 29, 2026
EPS expected
2.20
Beat in last 4
4 of 4
2026-06-30reported -0.13 vs -0.27 expected+52.3%
2026-03-31reported -1.28 vs -1.52 expected+16.0%
2025-12-31reported 2.09 vs 2.03 expected+3.0%
2025-09-30reported 2.68 vs 2.37 expected+13.1%
Analyst coverage
36 analysts · as of 2026-09-01Strong buy
8
Buy
18
Hold
10
Sell
0
Strong sell
0
News
stories naming this company, last 21 daysEvery figure here is measured from live market data as of Oct 4, 05:08 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.